Pediatric Pharmacology: Dr. Putrya Hawa, M.Biomed Faculty of Medicine, UII

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 27

Pediatric Pharmacology

dr. Putrya Hawa, M.Biomed


Faculty of Medicine, UII

Pediatric

Skin barrier

In topical administration

Muscle mass,
peripheral blood
flow

in i.m administration
toxicity

Liver blood flow

Pharmacodynamic
Immature neuromuscular junction
curare, atracurium

Drug Dosage
Pediatric dose:
1.Based on body weight
2.Young Formula
: adult dosage x age (years)
age + 12
3.Clarks Formula
: adult dose x weight (kg)
70

Example: Neonatal Sepsis


Leading cause of mortality in
premature neonates
Causes: Group B strep, E.coli,
Klebsiella,rare but serious Listeria
monocytogenes
Empiric therapy: ampicillin and
gentamicin
Safe, inexpensive, well studied

Gentamicin
Water-soluble with a large volume of
distribution
Approximately 0.6 L/kg in neonate
versus 0.25 L/kg in an adult
Renal elimination slower than adult
Half-life 3-10 hours in a neonate,
compared
to 1-2 hours in an adult

Gentamicin (Cont)
Target levels same as adults
Peak 4-8 mcg/mL, trough < 2 mcg/mL
Infused over 30 minutes
Usual dose 2.5 mg/kg given every 8 to
36
hours
Interval determined by weight,
gestational age, and renal function

Extended Gentamicin
Interval
Doses of 4 mg/kg given once daily in
larger newborns
Limited data in newborns < 32 weeks
GA
Risk for toxicity if unable to clear
large initial dose
Use with caution in infants with
potential renal impairment

Thank you

You might also like